Targeted delivery of RNA interference molecules for the treatment of IgEmediated disorders

Details for Australian Patent Application No. 2005214287 (hide)

Owner Genesis Research and Development Corporation Limited

Inventors Murison, Greg J.; Munro, Grant; Grigor, Murray Robert; Abernethy, Nevin; Havukkala, Ilkka Jaakko; Webster, Gill; Watson, James D.

Agent Shelston IP

Pub. Number AU-A-2005214287

PCT Pub. Number WO2005/080410

Priority 60/546,434 20.02.04 US

Filing date 21 February 2005

Wipo publication date 1 September 2005

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C07H 21/02 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

5 October 2006 PCT application entered the National Phase

  PCT publication WO2005/080410 Priority application(s): WO2005/080410

20 November 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005214291-Process for production of Chlorine Dioxide

2005214286-Classification, diagnosis and prognosis of acute myeloid leukemia by gene expression profiling